{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-090033","form_type":"8-K","ticker":"IDXX","cik":"0000874716","company_name":"IDEXX LABORATORIES INC /DE","filed_at":"2026-08-04T10:32:59+00:00","discovered_at":"2026-08-04T10:35:00.447678+00:00","generated_at":"2026-08-04T10:35:13.667094+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"IDEXX Laboratories Reports Q2 2026 Revenue of $1,217M and EPS of $4.27, Raises 2026 Outlook","bullets":["Revenue grew 10% as reported and 9% organic; CAG Diagnostics recurring revenue grew 11% as reported and 10% organic.","EPS of $4.27, up 18% as reported and 15% comparable; operating margin increased 140 bps as reported and 110 bps comparable.","IDEXX inVue Dx installed base surpassed 9,000 instruments, with over 1,600 placements during Q2 2026.","Narrows 2026 revenue guidance to $4,700M-$4,745M, up $5M at midpoint; raises EPS outlook to $14.69-$14.94.","Updates 2026 organic revenue growth outlook to 8.5%-9.7% and CAG Diagnostics recurring revenue organic growth to 9.5%-10.7%."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-090033","json":"https://secwatch.observer/filing/0001104659-26-090033.json","markdown":"https://secwatch.observer/filing/0001104659-26-090033.md","text":"https://secwatch.observer/filing/0001104659-26-090033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/874716/000110465926090033/0001104659-26-090033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/874716/000110465926090033/tm2622041d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T10:35:13.667094+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}